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INTRODUCTION 
Female hormonal contraception (FHC) and the 
subsequent social revolution first enabled the separation 
of sex and conception.
1
 However, options for men have 
not changed significantly in nearly a century, despite 
continued development of FHC. 
In recent years, as a result of this contraceptive 
inequality
2
 there have been concerted efforts to develop 
male hormonal contraception (MHC). To date, clinical 
trials have identified 13 different methods that could 
potentially be used for this purpose.
3
 Of these, combined 
androgen and progestin hormones appear to be the most 
promising for general use.
4
 
Despite public interest in this field, studies into the 
public's perspectives of MHC are sparse. Research has 
often only been undertaken through questionnaires 
completed alongside MHC clinical trials.  
The social history and lifespan issues of FHC have some 
resonance with MHC; for example, perceived existence 
of male inequities regarding their role in conception 
control. The social change caused by FHC, might be a 
predictor of similar changes for t MHCs with removal of 
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ABSTRACT 
Background: In recent years there have been great developmental advances in male hormonal contraception (MHC). 
Despite this, research relating to men‟s perspectives of MHC is sparse and is usually based on questionnaires 
completed as part of clinical trials. This study explored men‟s perspectives of MHC, specifically how they were 
formed and what factors might be influencing them. 
Methods: This qualitative study used semi-structured interviews with 10 heterosexual men aged between 18 and 44 
within the UK. Using a philosophical standpoint of social constructionism, data were analysed employing a modified 
grounded theory method. Joint analysis and reflexivity were applied to reduce bias and ensure rigour in the analytical 
process. 
Results: Four principal higher order themes emerged from the data: Sexual health and trust within a sexual 
relationship; Choice; Change; and Health. This paper presents the findings from the first two. Participants believed 
that MHC use would be affected by issues such as individual sexual relationships, sexual health, and trust. Issues 
relating to efficacy, contraceptive choice, age, knowledge and methods of administration were seen as core issues 
relating to the decision to take a MHC drug. 
Conclusions: This study was successful in its aim, finding that overall MHC would be well received by men and that 
their perspectives were not that different from attitudes towards female hormone contraception. It also identified 
potential barriers based on the concerns that men have for themselves and for society were an MHC to become 
available. 
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this inequality, and may cause similar social change. 
Importantly, historical reflection on FHC cannot provide 
insights into the thoughts, feelings and background mind 
of the men affected by the change.  
This study aimed to explore the perspectives men have of 
MHC, how these perspectives were formed, and what 
factors might be influencing them, in order to establish 
what issues may arise should an MHC become available. 
METHODS 
For this exploratory study a social constructionist 
approach was taken, allowing the researchers to examine 
men‟s views of the phenomenon of hormonal 
contraception through enquiry into their individual 
understandings and interpretations of the world.
5,6
 
Understanding and perspectives of MHC are likely to be 
reflective of participants‟ existing knowledge and 
experiences, which in this case are unlikely to include 
direct contact with an MHC (as none are presently 
licensed for use).  
Following ethical approval, participants were recruited 
from a population of male students and staff from a UK 
university through two different methods: direct 
recruitment by posters placed on noticeboards and 
emailing via the student and staff forum pages, and 
through snowballing via professional and personal 
contacts. To meet the aims of this study a sample of 
between 6-12 participants was considered.
7
 The final 
number was 11 (10 plus a pilot interview) and was based 
on achieving thematic saturation (see table 1). 
Inclusion/exclusion criteria were based on previous MHC 
clinical trials; transgender men were excluded.
8
 These 
criteria were chosen as the study required a sample to 
whom MHC would be directly rather than indirectly 
relevant.  
After an information leaflet and consent form had been 
sent, mutually convenient semi-structured individual 
interviews were arranged, mostly conducted on the 
University campus, audio-recorded, and lasting no more 
than one hour.  
An interview guide including topics such as relationships, 
heath and age was developed from relevant literature and 
from the researchers‟ expertise. Demographic data were 
collected at the beginning of the interview and at its 
conclusion the main discussion points were summarised 
as a form of respondent validation and to give the 
participant the opportunity to expand on areas discussed.
9
 
Participants were given a numerical identifier to maintain 
anonymity. The lead researcher, AL, undertook all the 
interviews and transcription. 
A pilot interview was carried out to assess and review 
feasibility, methods, timing and the interview guide, and 
to ensure that the data generated addressed the aims of 
the research.  
Interviews and analysis were conducted in parallel over a 
6-week period, allowing for emergent themes to be 
explored within subsequent interviews. Data analysis was 
performed using a modified grounded theory method
10 
through NVivo and any notes generated from the 
interviews were filed alongside the corresponding 
transcript.  
Each transcript was read, coded and reviewed. This 
process involved going back to the original transcripts to 
ensure that the coding reflected the context from which it 
was drawn. This was repeated in the development of 
categories (a collection of codes that were similar in 
content), themes (a collection of categories that were 
similar and added to the overall concept) and higher-
order themes (these were collections of themes sharing 
similar characteristics that captured the essence of 
participants‟ understanding and perspectives). The 
constant comparative method
11
 utilised throughout the 
analysis ensured rigour in the analysis and aided in a 
deeper understanding of concepts related to MHC being 
drawn from the data. 
Additionally, reflexivity was key throughout this research 
and included reflexive accounts prior to commencing the 
study to avoid bias from any pre-conceived ideas, 
feelings or perspectives.
12,13
 Additionally both researchers 
reviewed transcripts and data analysis, thereby creating 
an audit trail.
14
.  
RESULTS 
While four higher-order themes emerged from the 
analysis - Sexual health and trust within a sexual 
relationship; Choice; Change; and Health - this paper 
presents the findings from the first two. 
The participants‟ demographic table can be seen in Table 
1. 
Higher order theme: Sexual health and trust within a 
sexual relationship 
This higher-order theme encompassed findings around 
sexual relationships, including the length of a 
relationship, sexual health, and sexual behaviour and how 
these factors might impact on the use of an MHC and 
trust.  
Sexual relationships 
While some participants exclusively used condoms 
within a relationship, others felt that MHC would appeal 
to those in a long-term relationship by both enhancing 
sexual spontaneity and preventing pregnancy, as 
illustrated by the following quotations:  
“Maybe better using them in long term relationships as a 
preventative measure for pregnancy.” (P9; 54-56)  
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“I‟d be more likely to take it when you‟ve been with 
somebody 10, 15, 20 years and you know it‟s gonna, you 
know it‟s gonna last.” (P9; 466-467). However, one 
participant suggested that in more casual encounters its 
appeal was as contraceptive safeguard against failure of 
barrier methods.  
“Even when you‟re using condoms you know they 
break.” (P10; 439-440)  
For many participants, concerns about MHC‟s inability to 
protect against sexually transmitted infections (STIs) and 
the effect that this could have on STI transmission rates 
were an issue: 
“Would this give rise to greater cases of sexually 
transmitted diseases, possibly because people would then 
rely on this just for the sake of pregnancy not thinking 
about the sexually transmitted diseases?” (P5; 434-438)
 
Table 1: Participant demographics. 
Participant  Age Employment  Relationship status Children  
1 24 Medical student  Single  0 
2 34 Senior administrator Co-habiting  1 
3 37 Graphical designer  Married  0 
4 36 Teacher  Married 2 
5 37 Graphical designer Married 2 
6 24 Medical doctor In a relationship 0 
7 35 Senior carer Co-habiting 0 
8 30 Trainee teacher  Co-habiting 1 
9 34 Carer Married  2 
10 25 Programmer  Co-habiting 0 
 
Trust 
A key consideration for participants was trusting 
partners‟ effective use of any hormonal contraceptives.  
“There‟s a trust issue with blokes to women, I think there 
have been situations certainly where blokes have been 
told that a female might be on contraception and isn‟t and 
I think that goes both ways.” (P8; 311-314)  
“Would women trust blokes? I mean you‟ve heard they 
wouldn‟t, is it a trust issue? I think it can be overcome, 
yeah, because the only person you‟ve got to trust is 
yourself to take that pill or to have that jab.” (P8; 323-
326)  
The lack of observable evidence of FHC was discussed, 
with one participant saying that FHC has an “element of 
mystery” (P4; 105) relating to its effective use. So MHC 
in combination with FHC would add a layer of “in-built 
security” (P8; 327); if either contraceptive fails or is 
taken ineffectually, the other would protect against 
conception. 
Fidelity within the relationship, be it casual or long-term, 
was also a factor for participants when considering 
possible contraceptive behaviour. Participants felt that 
trust in a faithful partner was important in the use of 
MHC due to risk of STIs through infidelity: 
“I think I would probably be more likely to take it in a 
relationship than one - night stands because you do use 
protection for one-night stands whereas you wouldn‟t 
when you‟re in a relationship.” (P6; 37-39) 
“Well you‟ve got to trust the person you‟re with 'cause if 
they‟re sleeping around a lot then you don‟t know that 
that tablet that you‟re taking is stopping you getting the 
diseases that the other person might bring.” (P9; 456-458)  
Higher order theme: choice 
This higher order theme encompasses the various factors 
that would impact on men‟s choice to use a MHC, 
including attitude and lifestyle and the level of men‟s 
knowledge and understanding. 
General factors that impact on choice to use the male 
hormonal contraceptive. 
Participants generally received the idea of an MHC 
positively, feeling that it would be an acceptable 
alternative to current methods. However, they would 
want assurance of its efficacy; one participant suggested 
that he would want regular sperm count testing to achieve 
this, while others stated that they would be satisfied 
regarding efficacy if MHC were available through their 
doctor. Additionally, a range of MHC usage options, 
analogous to the FHC choices available to women, would 
be preferable as this would allow for adjustments on both 
side-effects and lifestyle. 
“I don‟t think a one pill fits all, I think that it would be 
beneficial to have choice on the market.” (P8; 269-271)  
Convenience was another consideration. An MHC that 
was active for 3-6 months per dose would be appealing 
and some participants stated that they would prefer to 
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avoid MHC injections -related partly to needle phobia 
and partly to a loss of control arising from the 
irreversibility of injected medications. Reversible 
methods (e.g. implant) or short acting methods (e.g. oral 
pill) would ameliorate long-term medication effects and 
an implant would have the additional advantage of 
convenience. 
“Would it be convenient for me to take a pill every day? 
Yes I think it an option it's fine. Would it be an implant? 
Which one would be easier if I compared the pill to the 
implant? I think implant would be easier 'cause I don‟t 
have to worry about it.” (P1; 409-411)  
Participants were divided when considering whether 
younger individuals would choose to use MHC. Half of 
the participants felt that MHC would not be appealing, as 
it does not protect against STIs, yet its appeal could be an 
extra layer of protection against pregnancy.  
“This isn‟t going to prevent any sexually transmitted 
diseases or anything like that so I think as a young chap 
who‟s out and about you know doing certain things it 
probably wouldn‟t appeal to them so much.” (P2; 127-
130)  
“Typical young free and single demographic who like to 
go out and have a bit of fun I think they‟d be quite open 
to the idea in terms of giving them an extra layer of 
protection.” (P8; 186-188)  
Interestingly, some participants also felt that an MHC 
would enable men to share the contraceptive pressure 
with women. 
“Only women have responsibility, you know to take the 
pill or the coil or the implant or whatever, but I think 
probably what we‟re seeing is it‟s becoming more of an 
equitable relationship.” (P4; 154-157)  
Social attitudes towards men and family planning 
Some participants identified that social expectations 
concerning contraception and family planning differed 
between men and women. One participant suggested that 
while women are expected to be responsible for 
contraception, they also have the power over decisions 
when pregnancy occurs. Yet, as participant 8 discussed, 
there was a perception that men should have financial 
responsibility despite having no control following 
conception. 
“You have got is a culture in the UK where this hasn‟t 
been helped by things like the Child Support Agency 
where the bloke is always seen to have the easier ride, 
and you know if there is an unwanted pregnancy and that 
pregnancy is kept then it‟s the bloke who has to finance 
through the CSA. The male is often made to be the 
scapegoat.” (P8; 333-338)  
Lifestyle factors that affect whether to take 
contraceptive 
All but one of the participants commented on cost in their 
decision to use an MHC, comparing the cost of MHC 
against existing methods (both male and female), 
frequency of purchase, as well as the overall impact on 
their financial situation. Equivalent cost to FHC would be 
important to avoid inequality and unfairness and some 
felt that the NHS should support the cost of MHC in line 
with female contraceptives. 
For the majority of participants, convenience of MHC 
access and compatibility with their lifestyles were 
important, with an expectation that MHC would be 
available through established access points for FHC (such 
as pharmacies or family planning clinics). Six 
participants said that access to the drug would need to be 
controlled, either through prescription from a doctor or 
through a pharmacist. 
“You‟d probably want it from a doctor or a chemist or a 
sort of reputable source.” (P4; 296-298)  
“All the drug thing for me is just, it‟s to get rid of all the 
hassle. If there‟s hassle at the other end of the drug taking 
then it probably would put me off.” (P3; 223-226)  
Most of the participants felt they would have to consider 
the risks and benefits before choosing to use an MHC, 
and would be more receptive if there were reduced 
probability of severe side-effects, such as loss of long-
term fertility.  
This was balanced by participants suggesting they were 
likely to use a contraceptive for relatively short periods of 
time (1-10 years), though it was acknowledged that this 
would depend on their situation. Three participants felt 
that being responsible for contraception would assist in 
the prevention of unplanned pregnancies, thus giving men 
equal choice of when to start a family. 
“It‟s a shared experience you can, you can just you can be 
part of that and not just give all the responsibility to a 
lady who is taking the pill every single day, whatever 
type of it, and then suffering through the side-effects. It‟s 
unfair I think. So if there‟s another way of making it kind 
of equal I think people will be a little bit happier.” (P2, 
172-175) 
Level of understanding of contraceptive methods 
All participants had experience of current methods of 
contraception. However, their level of knowledge about 
FHC methods varied; such prior knowledge seemed to be 
a major source of information when considering MHC. 
However, they did feel that before making a choice 
regarding MHC it would be important to have a good 
understanding of how it works and the possible side-
effects. 
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“If you understand the reasons why you‟re taking the, the 
tablets or whatever, when you know that there‟s going to 
be this side-effect there‟s less of a shock to you.” (P9; 
111-113)  
Participant 11 expressed concern about his lack of 
understanding of the male hormonal cycle, and how 
sperm is produced. For this reason he was concerned 
about the impact an MHC would have on his hormonal 
cycle.  
“I don‟t think really think there‟s been the same level of 
research into what‟s actually going on in, like, men‟s 
cycle, like if there is even a cycle cause there‟s all this 
kind of people saying that men have their periods and 
stuff they have their hormonal moments and stuff like 
that but they don‟t really know what‟s that‟s caused by.” 
(P11, 62-66). 
DISCUSSION 
This study has illuminated some of the perspectives and 
attitudes that men hold in respect of MHC. Reflecting 
findings by Eberhardt et al, participants in this study 
suggested that established relationships are most suited to 
MHC due to the lack of protection that it provides against 
STIs.
15
 The assumption that established relationships are 
less risky than casual encounters is interesting. In one 
sense this seems logical; fewer partners imply lower risk. 
However, there are two situations in which STIs may be 
transmitted between people within established 
relationships; partners may have undetected STIs that 
predate the relationship, or partners may have sex with 
others while maintaining their current relationship.  
Most participants suggested that the risk posed by casual 
sex meant that they would always use condoms. 
However, there is little difference in terms of risk 
between casual and new relationships; unless STI 
screening has been conducted prior to sex without 
condoms within a new relationship, the risk may be 
similar to that of a casual sexual encounter. Flood‟s study 
suggests that condoms are commonly exchanged for 
FHCs early in relationships and this shift is described as 
demonstrating trust that a partner is faithful.
16-18
 The 
social convention of fidelity within established 
relationships and the sense of security that this brings 
could blind people to the risk of STIs from their partner. 
However, although it has been shown that the risks of 
STIs do not disappear in established relationships, it still 
seems reasonable to suggest that the risk is reduced when 
compared to sexual activity outside such relationships. 
While the fact that condoms protect against both 
pregnancy and STIs was reported as the main advantage 
of the method, participants also discussed the possibility 
that MHC would result in an increase of STI transmission 
rates. They suggested this could be due to a greater 
concern about pregnancy than about STI transmission. 
Flood‟s participants also felt they were more likely to be 
involved in a conception than in obtaining an STI.
 16
 This 
finding is interesting as it contradicts the participants‟ 
self-assessment of their risk calculation. Many of the 
participants in our study stated that they would always 
use condoms when having casual sex. However, the 
prevailing sense both in this and in Flood‟s study is that 
„other people‟ are unlikely to take such care.16 On this 
basis it is difficult to know which would be the actual 
behaviour of the participants; and as a consequence 
participants‟ predictions of increased STI transmission 
may be based on their possible previous sexual 
behaviour. An alternative explanation for this 
discrepancy in belief is that, since the introduction of the 
Sexual Health Strategy, sexual health has become a 
prominent issue socially, within the NHS and the 
media.
23
 Perhaps this increased exposure to STI 
information has resulted in the participants‟ perception 
that even though they themselves are not unsafe, others 
are irresponsible.  
Sharing contraceptive responsibility within established 
relationships was discussed, with most participants 
feeling that the introduction of an MHC would increase 
equality within a relationship, offering an opportunity for 
men to share or fully assume the burden of contraceptive 
responsibility and side effects. This finding is consistent 
with previous studies, and perhaps the reason participants 
feel an MHC would increase equality is because there is 
presently no analogous alternative to the FHC.
15,19-22
 It is 
arguable that condoms already provide this opportunity to 
share responsibility, as agreement has to be reached 
between both individuals to use them, yet condoms are 
widely reported as an undesirable method due to 
perceived inconvenience and loss of sexual sensation.
16
 
However, with current FHC methods (as would be the 
case with MHC), the decision to use it is often a personal 
choice and independent of consideration of others.  
A significant additional significant finding was that 
participants suggested that MHC usage preferences may 
change dependent on age, with older men being 
considered less likely to use MHC. Their reasoning was 
that older men tend to have older partners who may have 
gone through the menopause. This is not necessarily the 
case, and thus some older men may continue to want to 
use an MHC. However, it is possible that these men may 
opt for vasectomy instead, especially if they have 
fathered as many children as they want to. The advantage 
of MHC for some men is its reversibility, which perhaps 
for the reasons above older men would not desire. 
Trust 
Trust was raised by a number of participants, with 
comments being focussed on two elements: trust within 
the relationship and trust in the efficacy of the MHC. 
Trust within the relationship related to men's concerns 
regarding the risk of unplanned pregnancies, specifically 
the trust that they have to put in a woman to manage 
contraception. This issue was raised by one participant 
Lloyd AL et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2546-2552 
International Journal of Reproduction, Contraception, Obstetrics and Gynecology                                     Volume 5 · Issue 8    Page 2551 
reporting friends who were misled by women who said 
they were taking a contraceptive; however this situation 
is not limited to casual sexual encounters.  
This mistrust is not specific to men; it appears to be a 
common basis of women's opposition to MHCs.
19,24,25
 As 
noted earlier, Flood found that condoms are exchanged 
for FHCs early in a relationship in those cases where men 
trust both their partner and the contraceptive method.
16
 
However, the literature suggests that this would not be 
the case for MHCs, as women are reportedly less likely to 
trust men to be responsible for contraception.
15,19,22
 Some 
of the participants within this study said that they used 
condoms as their only form of contraception within their 
relationship. This suggests that their partners do trust 
them with this responsibility. Glasier et al
 
shared this 
view; they showed that only 2% of their large, cross-
cultural female sample (n = 1894) would not trust their 
partner to take an MHC.
26
 In circumstances where trust 
was not certain, the administration route may provide 
sufficient evidence to satisfy a partner. Drugs given as 
either an injection or an implant would be self-evidential, 
allaying partners concerns regarding effective adherence 
to the medication. 
The issue of mistrust of both the efficacy of MHC and 
men‟s management of contraception seems to be present 
equally in men and women. A major factor in this may be 
the novelty of this method. Some participants suggested 
that an MHC would replace FHCs in their relationships. 
Others suggested that they would prefer to take it 
alongside their partner's FHC. Meriggiola found that only 
38% of their male sample would assume full 
contraceptive responsibility.
20
 One participant in our 
study felt that the addition of an MHC would increase 
control over paternity. He felt that the addition of an 
MHC would remove the need for trust, as each individual 
could be responsible for their own contraception, 
reflecting walker's
 
findings.
19
 The potential for 
independent complementary contraceptive methods could 
cause an equalisation in trust, possibly affecting the 
social relations surrounding family. 
Some findings related to an overall inclination to 
minimise personal adaptation expressed as a desire for 
convenience; that, ideally wants MHC to fit their 
lifestyle. This desire may have been the basis of 
participants‟ expectations of accessing MHC via the 
existing routes for FHC. This seemed to relate to the 
flexibility that the range of these routes provided. 
Additionally, convenience remained an issue within 
preferences regarding the route of administration; this 
and control over the duration of effect of MHC (in case 
of undesirable effects) were important features of any 
such route. It was felt that implants and oral pills would 
be desirable to manage undesirable effects, but 3–6 
monthly injections would not. Importantly, while other 
research has identified that preferences exist, it has not 
hitherto explored the reasons for these preferences.  
Our findings on cost suggested that barriers to acceptance 
may arise if MHC were to be priced higher than FHC 
(which is presently a prescription exempt from charge in 
the UK). However, it must be noted that equality of cost 
would impose a financial burden on the NHS, and would 
also imply an equal priority on MHC and FHC in terms 
of social attitudes and public policy. This is particularly 
interesting, as participants stated that MHC would not 
bring with it a need for social change, though this view 
seemed to be related more to moral or social issues – 
such as those that FHC faced at its introduction – than to 
changes at policy level. 
In summary, the principal findings from this study were 
that men would use an MHC, and that they want it to be 
similar to existing FHCs. Nonetheless, participants raised 
a number of issues that may present barriers to its 
introduction and uptake if not addressed, and these have 
been discussed in detail. Though not expressed directly 
by participants, it appears that the introduction of an 
MHC has the potential to have a dramatic social impact. 
FHC is currently exempt from prescription charge in the 
UK, and the expectation would be for MHC to also be 
exempt. Therefore companies, government departments 
and NHS policy makers will need to consider carefully 
the price of any resultant drug. Potentially, any man 
could use an MHC and policy makers may therefore need 
to consider which male groups are targeted to ensure 
efficiency of expenditure within the NHS.  
CONCLUSION 
This study has provided an insight into men's 
perspectives of MHC. It has identified some of the 
practical desires that men hold regarding MHCs as well 
as some of the concerns that they would have for 
themselves and for society were they to become 
available. This research has also raised some interesting 
questions relating to male identity in regard to MHC and 
social implications of its release. Further research could 
usefully explore these issues further. 
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